Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.68%
#4 Velvet Velvet +29.04%
#5 Cross Cross +22.45%
#6 Akedo Akedo +17.41%
#7 DoubleZero DoubleZero +14.34%
#8 Cap Cap +11.68%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.22%
#10 HOME HOME +10.23%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Fabino Enterprises Ltd Fabino Enterprises Ltd

Fabino Enterprises Ltd

FABINO
Rank in Stocks #39501
Operating from its Sonipat, India base since its incorporation in 2011, Fabino... Operating from its Sonipat, India base since its incorporation in 2011, Fabino Enterprises Limited is engaged in the manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-oriented consumer products throughout India. Its extensive product portfolio, marketed under the Fabino and Keepshine brands, includes allopathic and select herbal medications—such as tablets, ointments, and syrups—along with various food and general wellness items. The company also extends its reach globally by exporting wellness and Fast-Moving Consumer Goods (FMCG) like coffee, malt powder, protein powder, and hair shampoo. Fabino's products are distributed and promoted via its own robust internal network and specialized sales force. Notably, the entity adopted its current name, Fabino Enterprises Limited, in June 2024, having previously been known as Fabino Life Sciences Limited.
Share Price
$0.22413867
Last synced: 2026-05-25
Market Cap
$463.14K
Change (1 day)
0.00%
Change (1 year)
-24.40%
Country
IN
Trade Fabino Enterprises Ltd (FABINO)

Category

Healthcare
P/B ratio for Fabino Enterprises Ltd (FABINO)
P/B ratio as of 2026 TTM: 0
According to Fabino Enterprises Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Fabino Enterprises Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US